Harrow Health, Inc. (HROW) Social Stream



Harrow Health, Inc. (HROW): $7.02

-0.36 (-4.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Harrow Health Inc (HROW) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering HROW.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-11 3 $16.5 $15 $15.833 $6.82 132.16%
2022-03-18 3 $17 $15 $16.166 $6.82 137.04%

The Trend in the Analyst Price Target


Over the past 52 weeks, HROW's average price target has gone up $1.67.

Over the past 50 weeks, HROW's average upside potential has been 71.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 0 15.00 15 15.000 9.02 66.3%
2021-08-14 2 16.00 15 15.420 9.04 70.58%
2021-09-04 2 15.25 15 15.130 10.42 45.2%
2021-09-18 2 15.25 15 15.130 9.49 59.43%
2022-03-11 3 16.50 15 15.833 7.31 116.59%

HROW Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 120 days, HROW's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HROW as an investment opportunity.

  • In terms of how Harrow Health Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 22.3% of that group.
  • In terms of how Harrow Health Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than 76.46% of that group.
  • In terms of how Harrow Health Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 53.11% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Harrow Health Inc's upside potential (average analyst target price relative to current price) is greater than 121.11% of them.

In the Pharmaceutical Products industry, HOWL, HGEN, and GTHX are the three stocks most similar to Harrow Health Inc regarding the price target and analyst recommendation information presented here.

Is HROW a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.565 seconds.